Sequencing of the S1 genes of nine Australian strains of infectious bronchitis virus (IBV) identified two genotypically distinct groups of strains. The strains Vic S, V5/90, N1/62, N3/62, N9/74 and N2/75 comprised group I, sharing 80.7-98-3 % identity in their deduced amino acid sequences. All group I strains were able to replicate in the trachea and kidney but only four strains, Vic S, N1/62, N9/74 and N2/75, were nephropathogenic, the latter three causing mortalities ranging from 32 to 96%. Group II contained strains N1/88, Q3/88 and V18/91 which only replicated in the trachea, inducing no mortalities. These viruses showed 72.3-92.8 % amino acid identity to each other and only 53.8-61.7 % identity to viruses of the first group. They were also distinct from the Massachusetts 41 and D1466 strains (47-5-55.7% amino acid identity). Thus N1/88, Q3/88 and V18/91 form a new group of viruses which are genotypically distinct from all previously characterized IBV strains. No definite correlations were established between the S1 amino acid sequences and the nephropathogenicity of strains.
Infectious bronchitis virus (IBV), a member of the family Coronaviridae, causes an acute, highly contagious disease of chickens of all ages resulting in significant economic losses. The trachea is the primary target organ for virus attachment and replication, but some strains can also replicate in the kidneys. The IBV genome consists of a single strand of positive-sense RNA, 27.6 kb in length (Boursnell et al., 1987) . The genome encodes three major structural proteins, the spike glycoprotein (S), membrane glycoprotein (M) and the nucleocapsid protein (N). The S glycoprotein, which forms the peplomers seen at the surface of the virus, is post-translationally cleaved into the N-terminal S1 and C-terminal $2 glycoproteins. A number of important biological functions are associated with the S1 glycoprotein; it induces haemagglutinationinhibiting and virus-neutralizing antibodies and is involved in protection (Cavanagh et al., 1986; Ignjatovic & Galli, 1994) . The N terminus of the S1 glycoprotein may * Author for correspondence. Fax +61 3 9347 4042. e-mail sapats@mel.dah.csiro.au
The sequence data reported here for the Australian IBV strains have been submitted to the GenBank database and assigned accession numbers U29519 (Vic S), U29520 (V5/90), U29522 (N1/62), U29453 (N3/62), U29452 (N9/74), U29523 (N2/75), U29450 (N1/88), U29451 (Q3/88) and U29521 (V18/91). play a role in determining IBV tissue tropism and virulence (Cavanagh et al., 1988; Kwon & Jackwood, 1995) . Sequence comparisons of the S1 glycoproteins of strains isolated from vaccinated chicken flocks in the USA, Europe and Japan have indicated that strains may differ by as little as 1% or as much as 23 % at the amino acid level (Niesters et al., 1986; Kusters et al., 1989a; Cavanagh et al., 1992) . The Dutch strain D1466 was found to be exceptionally different, sharing only 5l 56 % amino acid identity with other IBV strains (Kusters et al., 1989a) .
The evolution of IBV is believed to be complex, being influenced by a number of factors such as the use of multiple strains for vaccination, population density and host immune status. Point mutations, deletions, insertions and, less frequently, recombination were all shown to contribute to the evolution of IBV strains (Kusters et al., 1990; Cavanagh et al., 1992; Wang et al., 1993) . Australian IBV strains are believed to have evolved independently from those in other countries due to geographical isolation and restrictions on the importation of poultry and related biological products. Following the first isolation of IBV in Australia in 1962, many strains of different serotypes have been isolated from vaccinated and non-vaccinated flocks (Wadey & Faragher, 1981 ; Ignjatovic & McWaters, 1991) . Some of these strains were antigenically similar to vaccine viruses, whereas others were antigenically different and failed to cross-react with existing polyclonal sera and monoclonal antibodies (Ignjatovic & McWaters, 1991; Ignjatovic & Galli, 1995) . The purpose of this study was to examine Australian IBV strains isolated over a period of three decades (1962 to 1991) at the molecular level. The viruses were from both vaccinated and non-vaccinated flocks and showed differences in pathogenicity and antigenicity. We attempted to elucidate the mechanisms involved in their evolution and the genetic basis of their virulence. The results presented show that three of the most recently isolated viruses form a new genotypic group.
All strains were isolated from broilers, with the exception of N3/62 which was isolated from layers. Viruses were propagated in 10-day-old embryonated chicken eggs; virus serotype and infectivity were determined in tracheal organ cultures as described (Ignjatovic & McWaters, 1991) . For analysis of virus pathogenicity two groups of specific pathogen-free chicks, inbred white leghorns (Ignjatovic & Galli, 1994) , were inoculated intraocularly with 104 median ciliostatic doses of IBV at 2 weeks of age. Chicks from one group were removed at 3, 5, 7 and 10 days after infection and the trachea and kidneys were removed. Approximately half the sample of each tissue was processed for virus isolation as described (Ignjatovic & Galli, 1994) . The remaining tissues were fixed in 10 % buffered formalin, stained with haematoxylin and eosin, and examined for lesions indicative of IBV infection (Siller & Cumming, 1974) . In the second group mortality was recorded daily until 14 days after infection.
The pathogenicities of nine strains of IBV are shown in Table 1 . All strains, with the exception of V5/90, were of a serotype that differed from the Vic S vaccine virus and all replicated in the trachea, inducing lesions. Although six strains were able to replicate in the kidney, only Vic S, N1/62, N9/74 and N2/75 induced lesions in the kidneys and were therefore classed as nephropathogenic strains. Three of these strains, N1/62, N9/74 and N2/75, caused mortalities of 90 %, 96 % and 32 %, respectively. The Vic S vaccine virus, although nephropathogenic, did not cause mortalities, consistent with its attenuation. The severity of the lesions did not correlate with mortalities. In the case of N9/74 the lesions were the least severe, possibly due to the extremely rapid course of the disease, with deaths occurring between 3 and 5 days after infection. Two strains, V5/90 and N3/62, replicated in the kidneys without causing visible lesions whereas N1/88, Q3/88 and V18/91 did not replicate in the kidneys.
The S1 genes of strains listed in Table 1 were cloned and sequenced. Virus RNA was purified essentially using the methods of Niesters et al. (1986) . Vic S, N1/88 and Q3/88 cDNAs were synthesized using random primers as described by Gubler & Hoffman (1983) with a commercial kit (Boehringer Mannheim). Sequences obtained from these clones were used to select primers for amplification of the S1 genes of N1/62, N3/62, N9/74, N2/75, V5/90 and V18/91 by reverse transcription and PCR. All cDNA was cloned into a pUC series plasmid and sequenced using the Pharmacia T7 sequencing kit.
Pairwise comparisons of the nucleotide and deduced amino acid sequences are shown in Table 2 . Strains formed two distinct genotypic groups. The first six strains, Vic S, V5/90, N1/62, N3/62, N9/74 and N2/75 (group I) were genetically related and shared greater than * The GenBank accession numbers M21883, X02342 and M21971 were used to obtain the published sequences for S 1 of strains M41, Beaudette (Beaud) and D1466, respectively. The percentage nucleotide and amino acid identity for the two proposed groups of Australian IBV strains are shaded.
82.8 % nucleotide and 80'7% amino acid identity. A similar level of amino acid variation within the S1 glycoprotein was reported previously for American, European and Japanese strains which shared between 77 % and 99 % amino acid identity (Niesters et al., 1986; Kusters et al., 1989a) . The group I viruses showed 75"6-80.0 % amino acid identity with the Massachusetts 41 strain. Strains within group I were isolated either before (N1/62, N3/62) or after (N9/74, N2/75, V5/90) the introduction of vaccination and were shown previously to be antigenically similar but not identical (Ignjatovic & McWaters, 1991) . Thus, genetic diversity existed in Australia before the introduction of vaccination in 1966. Strains isolated before this time (Vic S, N1/62 and N3/62) differed by as much as 19% in their S 1 amino acid sequences, were of a different serotype and differed in pathogenicity. Diversity continued after the introduction of vaccination and in fact the strains described here provide interesting examples of this diversity. V5/90 is very closely related to the vaccine virus Vic S and likely to be derived from it, possibly as a result of immune pressure in vaccinated flocks. N2/75 is a virus which has apparently accumulated a number of genetic changes (point mutations) compared with the other viruses of the 1960s, whereas it is probable that N9/74 is the result of the more major event of recombination. In the latter case, an examination of the nucteotide sequences showed that the S1 gene of N9/74 was similar to that of N3/62 except for the region corresponding to nucleotides 438-978 where the N9/74 sequence was more similar to N1/62 (data not shown).
The three IBV strains N1/88, Q3/88 and V18/91 formed a distinct and novel genotypic group (group II). They shared only 53.8-61.7 % identity at the amino acid level with the six strains in group I. Strains of this grouP showed no similarity to D1466, the only strain for which extensive amino acid variation has been previously reported (Kusters et al., 1989a) . N1/88 and Q3/88 were shown previously not to share any common antigenic determinants on either their S 1, $2, M or N proteins with group I strains (Ignjatovic & McWaters 1991 ; Ignjatovic & Galli, 1995) . In that respect they also differed from D 1466, which shared common $2 antigenic determinants with M41 (Kusters et al., 1989b) .
An alignment of the deduced amino acid sequence of the S1 gene of Vic S, including the signal sequence and the cleavage site, with that of the other strains is shown in Fig. 1 . The length of the Sl glycoproteins varied from 541 (N2/75) to 548 (Q3/88) amino acids. The differences in size resulted from insertions and deletions, most of which were located between residues 59 and 303. Seventeen of the 18 cysteine residues within Vic S were conserved. Additional cysteine residues were present in N1/88 (residues 211,240, 313) and Q3/88 (residue 35). The 18 potential glycosylation sites within Vic S were conserved in the majority of group ! strains. Variation in glycosylation sites was considerable in V18/91, N1/88 and Q3/88 which had 15, 16 and 17 sites, respectively. The majority of amino acid differences in the group I strains occurred within three regions corresponding to residues 53-152, 192-202 and 288 313 . In N1/88, Q3/88 and V18/91 the variation was distributed more evenly throughout S1. An alignment (data not shown) of S1 sequences presented here with those published for other strains identified only four conserved regions, corresponding to positions 29-33, 115-120, 242-251 and 516-520 in Fig. 1 . The detection of D1466 in Holland and the isolation of N1/88, Q3/88 and V18/91 indicate that the emergence of genotypically distinct groups of IBV is becoming more significant in IBV epidemiology. It is unknown why strains more closely related to N1/88 and Q3/88 were not detected prior to 1988. Both strains appeared suddenly during 1988 in broiler flocks at two distant locations. Data presented here, as well as previous results (Ignjatovic & McWaters, 1991) The complete deduced amino acid sequence of the S1 gene of Vic S is shown, including the signal sequence of 18 residues and the arginine-rich sequence containing the cleavage site between S1 and $2. Gaps (dashes) were introduced in order to align the sequences. Dots indicate residues identical to Vic S. Asterisks indicate amino acid residues that are conserved in all strains. Potential glycosylation sites (NXS or NXT, except where X = P) are underlined.
Regions of variability within the group I strains are shaded. The CLUSTAL V program was used for the multiple sequence alignment (Higgins & Sharp, 1988) .
Strain V5/90 was isolated at the same location a year earlier and, as results have shown, gave no indication of the impending antigenic change that occurred in V 18/91. Sequence analysis has indicated that V18/91 might have arisen from N1/88, although epidemiological evidence suggests that this is not likely (J. Ignjatovic, unpublished results) . One may speculate that the progenitors of the group II viruses were circulating for a prolonged period through immune layer populations without causing visible disease, but that during this time a significant number of mutations accumulated. Thus, genotypically distinct strains were generated which had a newly acquired capacity to infect and cause disease in broilers. However, we have not screened layers for the presence of the group II viruses and thus their origin and the mechanism involved in their generation are uncertain.
Comparison of the amino acid sequences of the nephropathogenic strains Vic S, N1/62, N9/74 and N2/75 with those of respiratory strains N3/62 and V5/90 failed to identify with certainty region(s) that could be correlated with the pathogenicity of these strains, This was largely due to the extensive amino acid variation shown among the nephropathogenic strains. The region between amino acid residues 123 and 152 ( Fig. 1 ) has previously been identified as a possible region involved in the differing pathogenicity of Gray (nephropathogenic) and non-virulent JMK strains (Kwon & Jackwood, 1995) . Similarly, Cavanagh et al. (1988) detected a difference in amino acid residue 126 between the nephropathogenic H52 strain and the attenuated H120 strain and speculated that this region might be involved in virulence. One amino acid change, from aspartic acid to glycine at position 126, in the respiratory strain V5/90 was observed in comparison to the nephropathogenic strain Vic S. Examination of this region in the other respiratory strains did not reveal an identical change, although additional amino acid changes were found on either side of position 126 in all strains. Whether this or some other region within S1 is responsible for the virulence of these strains remains to be confirmed. Virulence determinants in murine coronaviruses were found to be complex, associated with different regions of the S1 glycoprotein as well as with host-encoded factors (Taguchi et al., 1995) .
The phylogenetic relationship between Australian and other IBV strains, based upon the published S1 sequences, was analysed using the neighbour-joining method (Saitou & Nei, 1987) . The results (data not shown) indicated that the Australian strains formed two distinct phylogenetic groups well separated from American, European and Japanese strains. The group I Australian strains formed a distinct cluster with two sub-clusters, one containing Vic S, V5/90 and N2/75, the second containing N1/62, N3/62 and N9/74. The group II strains formed a cluster well separated from the other clusters, including the Dutch strain D1466. Thus, although the extent of changes within S1 of IBV strains can vary greatly, as was the case with group II strains, there is sufficient genetic uniformity to be consistent with the classification of all strains isolated worldwide into one species. SAlXOU, N. & NEI, M. (1987 
